BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Adheron Therapeutics is defunct.

Fate: Bought by Roche, Oct 2015, $105M + $475 Milestones


------------------
If you believe any of this information is incorrect, please let us know.